Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

1.3K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.3K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

764
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
764
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Stress and Mental Health01:30

Stress and Mental Health

1.1K
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
1.1K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

896
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.4K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review.

Journal of psychopharmacology (Oxford, England)·2026
Same author

The Serotonin 2B (5-HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression.

Clinical pharmacology and therapeutics·2026
Same author

Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations.

Expert opinion on drug metabolism & toxicology·2026
Same author

Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder: A Randomized Clinical Trial.

JAMA psychiatry·2026
Same author

Intranasal Ketamine for Existential Distress in Advanced Cancer.

Journal of pain and symptom management·2026
Same author

Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: A systematic review.

General hospital psychiatry·2026

Related Experiment Video

Updated: Mar 25, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

766

Bipolar Disorder and Inflammation.

Joshua D Rosenblat1, Roger S McIntyre1

  • 1Mood Disorder Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada.

The Psychiatric Clinics of North America
|February 16, 2016
PubMed
Summary
This summary is machine-generated.

Bipolar disorder (BD) pathophysiology is unclear, but innate immune dysfunction, marked by inflammation, is implicated. Anti-inflammatory treatments show promise for treating this mood disorder.

Keywords:
AntiinflammatoryBipolar depressionInflammationInfliximabInnate immune systemMinocyclineNACNSAIDs

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.6K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K

Related Experiment Videos

Last Updated: Mar 25, 2026

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

766
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.6K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Bipolar disorder (BD) pathophysiology is not well understood.
  • Current treatments for BD have limitations, including poor tolerability and treatment resistance.
  • Growing evidence suggests a role for innate immune system dysfunction in BD.

Purpose of the Study:

  • To explore the role of innate immune system dysfunction in bipolar disorder.
  • To investigate elevated proinflammatory cytokine levels in BD.
  • To evaluate the potential of the innate immune system as a therapeutic target for BD.

Main Methods:

  • Review of existing literature on BD pathophysiology and immune system involvement.
  • Analysis of studies reporting elevated proinflammatory cytokine levels in BD patients.
  • Examination of the anti-inflammatory properties of lithium and other agents.

Main Results:

  • Elevated proinflammatory cytokine levels are a consistent finding in BD.
  • The innate immune system presents a novel therapeutic target for BD.
  • Lithium exhibits anti-inflammatory properties relevant to BD treatment.

Conclusions:

  • Innate immune system dysfunction, particularly inflammation, is implicated in bipolar disorder pathophysiology.
  • Anti-inflammatory agents, potentially including lithium, represent a promising therapeutic avenue for BD.
  • Further research is warranted, but anti-inflammatory treatments may soon be integrated into clinical practice for BD.